Cargando…
Quetiapine: off-label prescribing in a community mental health team
AIMS: Quetiapine is an atypical anti-psychotic medication licensed for the treatment of schizophrenia, bipolar disorder and adjunctive use in major depressive disorder. It's off-label use in low doses is increasing, possibly due to its sedative qualities, tolerability, low risk of extrapyramida...
Autores principales: | Abdelgadir, Ala, Walsh, Richard, Walsh, Elizabeth, Patel, Sonn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8771915/ http://dx.doi.org/10.1192/bjo.2021.212 |
Ejemplares similares
-
Off-label prescribing of quetiapine in south locality crisis teams
por: Kumari, Mamta, et al.
Publicado: (2021) -
Reducing high dose antipsychotic therapy (HDAT) in a community mental health team (CMHT)
por: Walsh, Richard, et al.
Publicado: (2021) -
Patient factors associated with the use of psychotropic polypharmacy in patients under the care of a community mental health team in the West of Ireland
por: Srikumar, Karthika, et al.
Publicado: (2021) -
Off-label prescribing of quetiapine in HMP Elmley, a Category B remand prison: a re-audit
por: Igbinomwanhia, Nosa, et al.
Publicado: (2021) -
Professional training and case-load mix within a community mental health team
por: Walsh, Richard, et al.
Publicado: (2021)